Home medicines
 

Keywords :   


Tag: medicines

WA Governor Inslee signs interchangeable biologic medicines bill.

2015-05-18 14:31:08| Industrial Newsroom - All News for Today

BIO and Washington Biotechnology & Biomedical Association (WBBA) commend Governor Jay Inslee for signing Bill 5935, which creates pathway for substitution of interchangeable biologic medicines. Policies outlined in said bill align with BIO's principles on biologic substitution, and BIO president and CEO Jim Greenwood specifically noted included "communication on all biologic medicines dispensed in order to maintain a consistent and complete medical record."

Tags: bill signs governor medicines

 

BIO Lauds Bill regarding interchangeable biologic medicines.

2015-05-12 14:31:12| Industrial Newsroom - All News for Today

BIO and Georgia Bio (GaBio) commended Governor Nathan Deal for signing Senate Bill 51, which creates pathway for substitution of interchangeable biologic medicines. Policies outlined in said bill align with BIO's principles on biologic substitution. Citing bill's merits and noting broad support, BIO's Jim Greenwood said that signing this bill into law adds Georgia to states taking "a leadership position" in allowing retail pharmacies to substitute interchangeable biologic medicines."

Tags: bill bio medicines interchangeable

 
 

Aceto Corp. to roll out 2 generic eye medicines

2015-04-24 16:18:35| Chemicals - Topix.net

Aceto Corp. is rolling out two generic eye medicines to serve a U.S. market valued at $80 million per year, the Port Washington company said. Timolol Maleate Ophthalmic Solution, which will come in 0.25% and 0.5% strengths, is used to treat elevated intraocular pressure in patients with ocular hypertension and open-angle glaucoma.

Tags: eye roll corp generic

 

Merck Reaffirms Continued Commitment to Developing Innovative Medicines for the Treatment of Infectious Diseases at 25th Annual ECCMID Congress

2015-04-21 14:30:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today reaffirmed its longstanding commitment to discovering and developing novel medicines in the global fight against infectious diseases, including infections caused by resistant bacteria and other pathogens. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orRobert Consalvo, 908-295-0928orInvestors:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: treatment continued annual developing

 

Utah Governor signs Interchangeable Biologic Medicines bill.

2015-04-13 14:31:08| Industrial Newsroom - All News for Today

BIO commends Utah Governor Gary Herbert for signing into law important legislation that serves to update existing Utah laws governing substitution of interchangeable biologic medicines. House Bill 279 represents a significant step forward, ensures transparency and communication between patients and their treatment teams, and is fully consistent with BIO’s principles on biologic substitution. Therefore, BIO supports this legislation and is pleased to see Governor Herbert sign the bill into law.

Tags: bill signs utah governor

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] next »